Cytek Biosciences, Inc.CTKBNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank67
3Y CAGR+51.0%
5Y CAGR+68.7%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+51.0%/yr
Annual compound
5Y CAGR
+68.7%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
13.7x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$10.54M-28.9%
2024$14.82M+22.1%
2023$12.14M+296.1%
2022$3.06M+195.2%
2021$-3.22M-517.5%
2020$771000.00-19.9%
2019$962000.00-